Hinova Pharmaceuticals Inc. (SHA:688302)

Hinova Pharmaceuticals Revenue

Hinova Pharmaceuticals had revenue of 30.76M CNY in the quarter ending September 30, 2026, with 201.99% growth. This brings the company's total for the last twelve months to 82.85M, up 250.91% year-over-year. In the year 2025, Hinova Pharmaceuticals had annual revenue of 20.47M with 5,480.12% growth. That makes Hinova Pharmaceuticals the 36,362nd largest company in the world by revenue and 5,123rd in China.

• Revenue (ttm): 82.85M
• Revenue Growth: +250.91%
• P/S Ratio: 42.37
• Revenue / Employee: 316.21K
• Employees: 262
• Market Cap: 3.51B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 20.47M 100.0%
• Overseas 3.73K 0.0%

Fiscal year ended Dec 31, 2025 See the full Hinova Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.47M	20.10M	5,480.12%
Dec 31, 2024	366.84K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	1.65M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error